SPINK5 inhibits esophageal squamous cell carcinoma metastasis via immune activity

Jie Chen1, Juncheng Lu2, Zhiqiang Chen3

  • 1Department of Oncology, Jiangyin People's Hospital, Jiangyin Clinical College of Xuzhou Medical University, Jiangyin Hospital Affiliated to Nantong University, Jiangyin, Jiangsu, China.

PubMed
Abstract

Insights

Serine peptidase inhibitor Kazal-type 5 (SPINK5) is downregulated in esophageal squamous cell carcinoma (ESCC), inhibiting metastasis. SPINK5 influences the TLR4/NF-κB pathway and immune cell infiltration, offering potential diagnostic and therapeutic insights for ESCC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Esophageal squamous cell carcinoma (ESCC) is a significant cause of cancer mortality.
  • Serine peptidase inhibitor Kazal-type 5 (SPINK5) is observed to be downregulated in ESCC.
  • The precise function of SPINK5 in ESCC requires further elucidation.

Purpose of the Study:

  • To investigate the role of SPINK5 in ESCC.
  • To explore the relationship between SPINK5 expression and clinicopathological features.
  • To determine the impact of SPINK5 on ESCC cell invasion, migration, and the underlying molecular pathways.

Main Methods:

  • SPINK5 mRNA levels were quantified in tumor and adjacent non-cancerous tissues from 196 ESCC patients.
  • Transwell assays assessed the effects of SPINK5 on ESCC cell invasion and migration.
  • Mechanisms involving Toll-like receptor 4 (TLR4), nuclear factor-kappa B (NF-κB) signaling, and immune cell infiltration were analyzed.

Main Results:

  • SPINK5 mRNA was downregulated in ESCC tissues and correlated with increased lymph node metastasis.
  • Overexpression of SPINK5 suppressed ESCC cell invasion and migration.
  • SPINK5 negatively correlated with NF-κB pathway genes and modulated NF-κB promoter activity, while influencing immune cell infiltration and ESTIMATE scores.

Conclusions:

  • SPINK5 plays a crucial role in the TLR4/NF-κB pathway and immune cell infiltration in ESCC.
  • These functions of SPINK5 may contribute to ESCC metastasis.
  • SPINK5 presents potential as a biomarker for ESCC diagnosis and treatment.